A research project for the development of a new in-vitro diagnostic test for tuberculosis.

A research project for the development of a new in-vitro diagnostic test for tuberculosis. - TID-1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00014254

Enrollment

550

Registered

2018-07-10

Start date

2018-06-05

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A15

Interventions

Group 1: Adult males and females with an active tuberculosis disease. TB-disease must be confirmed with clinical symptoms and sputum culture, PCR, radiology or microscopy. Adult males and females wit

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: TB-infected participants - Signed informed consent - Age over 18 years - TB-disease confirmed with clinical symptoms and PCR, culture, radiology or microscopy. - Willing and able to donate 50mL blood

Exclusion criteria

Exclusion criteria: - Any condition or disorder that in the opinion of the investigator will make the participant inappropriate for study participation.

Design outcomes

Primary

Measure	Time frame
As part of the study, it will then be determined whether the determination of the immunological concentrations and the proposed evaluation algorithm are appropriate to differentiate the groups involved - participants subjects with a previous tuberculosis infection and participants subjects without a known infection.	—

Countries

Germany

Contacts

Public ContactNadin Graf

R-Biopharm AG

n.graf@r-biopharm.de+49 6151 8102 - 7204

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026